Ethical issues posed by cluster randomized trials in health research

Trials

Volumn 12, Issue , 2011, Pages

  Weijer, Charles ^a,b   Grimshaw, Jeremy M ^c,d   Taljaard, Monica ^c,d   Binik, Ariella ^a   Boruch, Robert ^e   Brehaut, Jamie C ^c,d   Donner, Allan ^b,f   Eccles, Martin P ^g   Gallo, Antonio ^a,h   McRae, Andrew D ^a,b,i   Saginur, Raphael ^j   Zwarenstein, Merrick ^k  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f ROBARTS RESEARCH INSTITUTE   (Canada)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h WESTERN UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

^k SUNNYBROOK RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; EQUIPOISE; ETHICAL DECISION MAKING; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; CLUSTER ANALYSIS; EDITORIAL; ETHICS; EVIDENCE BASED MEDICINE; PATIENT RIGHT; PATIENT SELECTION; RESEARCH ETHICS; RESEARCH SUBJECT; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICS; VULNERABLE POPULATION;

CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; ETHICS, RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; INFORMED CONSENT; PATIENT RIGHTS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; RISK ASSESSMENT; THERAPEUTIC EQUIPOISE; VULNERABLE POPULATIONS;

EID: 79954583413     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-100     Document Type: Article

References (50)

1. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research 2000, London: Arnold.
2. The COMMIT Group Community intervention trial for smoking cessation (COMMIT): I. Cohort results from a four-year community intervention. Am J Public Health 1995, 85(2):183-92. 1615326, 7856777, The COMMIT Group.
3. Lewin S, Dick J, Zwarenstein M, Lombard CJ. Staff training and ambulatory tuberculosis treatment outcomes: a cluster randomized controlled trial in South Africa. Bull World Health Organ 2005, 83(4):250-9. 2626204, 15868015.
4. Kennedy A, Robinson A, Hann M, Thompson D, Wilkin D. A cluster-randomised controlled trial of a patient-centred guidebook for patients with ulcerative colitis: effect on knowledge, anxiety, and quality of life. Health Soc Care Community 2003, 11(1):64-72. 10.1046/j.1365-2524.2003.00399.x, 14629234.
5. Halloran ME, Longini IM, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev 1999, 21(1):73-88.
6. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and Statistics in Medicine. Stat Med 2007, 26(1):2-19. 10.1002/sim.2731, 17136746.
7. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. Br Med J 2004, 328(7441):702-8.
8. Taljaard M, Weijer C, Grimshaw J, Belle Brown J, Binik A, Boruch R, Brehaut JC, Chaudhry S, Eccles MP, McRae A, Saginur R, Zwarenstein M, Donner A. Study protocol: Ethical and policy issues in cluster randomized trials: rationale and design of a mixed methods research study. Trials 2009, 10:61. 10.1186/1745-6215-10-61, 2725043, 19638233.
9. Eccles M, Steen N, Grimshaw J, Thomas L, McNamee P, Soutter J, Wilsdon J, Matowe L, Needham G, Gilbert F, Bond S. Effect of audit and feedback, and reminder messages on primary-care radiology referrals: a randomised trial. Lancet 2001, 357(9266):1406-9. 10.1016/S0140-6736(00)04564-5, 11356439.
10. Hutton JL, Eccles MP, Grimshaw JM. Ethical issues in implementation research: a discussion of the problems in achieving informed consent. Implement Sci 2008, 3:52. 10.1186/1748-5908-3-52, 2639614, 19091100.
11. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355(26):2725-32. 10.1056/NEJMoa061115, 17192537.
12. Wenzel RP, Edmond MB. Team-based prevention of catheter-related infections. N Engl J Med 2006, 355(26):2781-3. 10.1056/NEJMe068230, 17192545.
13. 45 Code of Federal Regulations 46.101(b)(4) date accessed: April 19, 2011., http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=26deb50e7f77001a876fde96d3a2b8e3&rgn=div5&view=text&node=45:1.0.1.1.25&idno=45;
14. Miller FG, Emanuel EJ. Quality-improvement research and informed consent. N Engl J Med 2008, 358(8):765-7. 10.1056/NEJMp0800136, 18287598.
15. Kass N, Pronovost PJ, Sugarman J, Goeschel CA, Lubomski LH. Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research. Jt Comm J Qual Patient Saf 2008, 34(6):349-53.
16. Levine RJ. Ethics and Regulation of Clinical Research 1988, New Haven: Yale University Press.
17. Weijer C, Lanata CF, Plowe CV. Ethical considerations in the conduct of vaccine trials in developing countries. New Generation Vaccines 2010, 59-65. New York: Informa Health Care, Inc, Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R, 4.
18. Weijer C, Miller PB. When are research risks reasonable in relation to anticipated benefits?. Nat Med 2004, 10(6):570-3. 10.1038/nm0604-570, 15170195.
19. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987, 317(3):141-5. 10.1056/NEJM198707163170304, 3600702.
20. Fuks A, Weijer C, Freedman B, Shapiro S, Skrutkowska M, Riaz A. A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. J Clin Epidemiol 1998, 51(2):69-79. 10.1016/S0895-4356(97)00240-0, 9474067.
21. Caldwell P, Murphy S, Butow P, Craig J. Clinical trials in children. Lancet 2004, 364(9436):803-11. 10.1016/S0140-6736(04)16942-0, 15337409.
22. Dresser R. Wanted: single, white male for research. Hastings Cent Rep 1992, 22(1):24-9. 10.2307/3562720, 1428831.
23. Childress JF. Compensating injured research subjects: the moral argument. Hastings Cent Rep 1976, 6(6):21-7. 10.2307/3561144, 993009.
24. Weijer C, Emanuel EJ. Protecting communities in biomedical research. Science 2000, 289(5482):1142-4. 10.1126/science.289.5482.1142, 10970227.
25. Ross LF, Loup A, Nelson RM, Botkin JR, Kost R, Smith GR, Gehlert S. The challenges of collaboration for academic and community partners in a research partnership: points to consider. J Empir Res Hum Res Ethics 2010, 5(1):19-31. 10.1525/jer.2010.5.1.19, 2946316, 20235861.
26. Baily MA. Harming through protection?. N Engl J Med 2008, 358(8):768-9. 10.1056/NEJMp0800372, 18287599.
27. Siegel MD, Alfano SL. The ethics of quality improvement research. Crit Care Med 2009, 37(2):791-2. 10.1097/CCM.0b013e318194c4d6, 19325394.
28. Savel RH, Goldstein EB, Gropper MA. Critical care checklists, the Keystone Project, and the Office for Human Research Protections: A case for streamlining the approval process in quality-improvement research. Crit Care Med 2009, 37(2):725-8. 10.1097/CCM.0b013e31819541f8, 19114910.
29. Baily MA, Bottrell M, Lynn J, Jennings B. The ethics of using QI methods to improve health care quality and safety. Hastings Cent Rep 2006, 36(4):S1-S39. 10.1353/hcr.2006.0054, 16898359.
30. 45 Code of Federal Regulations 46.102(f) date accessed: April 19 2011., http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=26deb50e7f77001a876fde96d3a2b8e3&rgn=div5&view=text&node=45:1.0.1.1.25&idno=45;
31. Mann H, Reyes M. Identifying the human research subject in cluster randomized controlled trials. IRB 2008, 30(5):14-8.
32. Edwards SJL, Braunholtz DA, Lilford RJ, Stevens AJ. Ethical issues in the design and conduct of cluster randomised controlled trials. Br Med J 1999, 318(7195):1407-9.
33. Medical Research Council Cluster Randomised Trials: Methodological and Ethical Considerations date accessed: April 19, 2011, Medical Research Council., http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002406;
34. 45 Code of Federal Regulations 46.116(d) date accessed: April 19 2011., http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=26deb50e7f77001a876fde96d3a2b8e3&rgn=div5&view=text&node=45:1.0.1.1.25&idno=45;
35. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials 2005, 2(2):91-8. 10.1191/1740774505cn070oa, 16279130.
36. Glanz K, Rimer BK, Lerman C. Ethical issues in the design and conduct of community-based intervention studies. Ethics and Epidemiology 1996, 156-77. Oxford: Oxford University Press, Coughlin SS, Beauchamp TL.
37. Herrera MG, Nestel P, el Amin A, Fawzi WW, Mohamed KA, Weld L. Vitamin A supplementation and child survival. Lancet 1992, 340(8814):267-71. 10.1016/0140-6736(92)92357-L, 1353192.
38. Ghana VAST Study Team Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet 1993, 342(8862):7-12. 10.1016/0140-6736(93)91879-Q, 8100345, Ghana VAST Study Team.
39. Klar N, Donner A. Ethical challenges posed by cluster randomization. Wiley Encyclopedia of Clinical Trials 2007, 1-5.
40. Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med 2004, 350(11):1143-7. 10.1056/NEJMsb033476, 15014189.
41. Miller PB, Weijer C. Fiduciary obligations in clinical research. J Law Med Ethics 2006, 34(2):424-40. 10.1111/j.1748-720X.2006.00049.x, 16789965.
42. Hearnshaw H. Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional study. Br Med J 2004, 328(7432):140-1.
43. Kopelman LM. Children as research subjects: a dilemma. J Med Philos 2000, 25(6):745-64.
44. Althabe F, Buekens P, Bergel E, Belizan JM, Campbell MK, Moss N, Hartwell T, Wright LL. A behavioral intervention to improve obstetrical care. N Engl J Med 2008, 358(18):1929-39. 10.1056/NEJMsa071456, 18450604.
45. Hickman M, McDonald T, Judd A, Nichols T, Hope V, Skidmore S, Parry JV. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral Hepat 2008, 15(4):250-4. 10.1111/j.1365-2893.2007.00937.x, 18086182.
46. Kipping RR, Jago R, Lawlor DA. Diet outcomes of a pilot school-based randomised controlled obesity prevention study with 9-10 year olds in England. Prev Med 2010, 51(1):56-62. 10.1016/j.ypmed.2010.04.011, 20406655.
47. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360(1):20-31. 10.1056/NEJMoa0800394, 19118302.
48. Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, Wickramaratne P, Speelman L, Ndogoni L, Weissman M. Group interpersonal psychotherapy for depression in rural Uganda. JAMA 2003, 289(23):3117-24. 10.1001/jama.289.23.3117, 12813117.
49. Hutton JL. Are distinctive ethical principles required for cluster randomized controlled trials?. Stat Med 2001, 20(3):473-88. 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D, 11180314.
50. Marshall P, Rotimi C. Ethical challenges in community-based research. American Journal of Medical Science 2001, 322(5):241-5.